메뉴 건너뛰기




Volumn 47, Issue 6, 2007, Pages 738-743

Meeting review: Effective integration of systems biology, biomarkers, biosimulation, and modeling in streamlining drug development

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

EID: 34249073680     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270007300746     Document Type: Conference Paper
Times cited : (10)

References (12)
  • 1
    • 0034029795 scopus 로고    scopus 로고
    • Optimizing the science of drug development: Opportunities for better candidate selection and accelerated evaluation in humans
    • Lesko L., Rowland M., Peck CC, Blashcke T. Optimizing the science of drug development: opportunities for better candidate selection and accelerated evaluation in humans. Eur J Pharm Sci. 2000 ; 10 :iv-xiv.
    • (2000) Eur J Pharm Sci. , vol.10
    • Lesko, L.1    Rowland, M.2    Peck, C.C.3    Blashcke, T.4
  • 2
    • 0034963603 scopus 로고    scopus 로고
    • EUFEPS conference report. Optimising drug development: Strategies to assess drug metabolism/transporter interaction potential-towards a consensus. European Federation of Pharmaceutical Sciences
    • Tucker GT, Houston JB, Huang SM EUFEPS conference report. Optimising drug development: strategies to assess drug metabolism/transporter interaction potential-towards a consensus. European Federation of Pharmaceutical Sciences. Eur J Pharm Sci. 2001 ; 13: 417-428.
    • (2001) Eur J Pharm Sci. , vol.13 , pp. 417-428
    • Tucker, G.T.1    Houston, J.B.2    Huang, S.M.3
  • 3
    • 0037384066 scopus 로고    scopus 로고
    • Use of biomarkers from drug discovery through clinical practice: Report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development
    • Rolan P., Atkinson A., Lesko L. Use of biomarkers from drug discovery through clinical practice: report of the Ninth European Federation of Pharmaceutical Sciences Conference on Optimizing Drug Development. Clin Pharmacol Ther. 2003 ; 73: 284-291.
    • (2003) Clin Pharmacol Ther. , vol.73 , pp. 284-291
    • Rolan, P.1    Atkinson, A.2    Lesko, L.3
  • 4
    • 28244484349 scopus 로고    scopus 로고
    • Getting the dose right: Report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development
    • Stanski DR, Rowland M., Sheiner LB Getting the dose right: report from the Tenth European Federation of Pharmaceutical Sciences (EUFEPS) conference on optimizing drug development. J Pharmacokinet Pharmacodyn. 2005 ; 32: 199-211.
    • (2005) J Pharmacokinet Pharmacodyn , vol.32 , pp. 199-211
    • Stanski, D.R.1    Rowland, M.2    Sheiner, L.B.3
  • 5
    • 0033920653 scopus 로고    scopus 로고
    • New safe medicines faster: A proposal for a key action within the European Union's 6th framework programme
    • Bjerrum OJ New safe medicines faster: a proposal for a key action within the European Union's 6th framework programme. Pharmacol Toxicol. 2000 ; 86 (suppl 1). 23-26.
    • (2000) Pharmacol Toxicol. , vol.86 , Issue.1 , pp. 23-26
    • Bjerrum, O.J.1
  • 6
    • 4344645978 scopus 로고    scopus 로고
    • Can the pharmaceutical industry reduce attrition rates
    • Kola I., Landis J. Can the pharmaceutical industry reduce attrition rates ? Nat Rev Drug Discov. 2004 ; 3: 711-715.
    • (2004) Nat Rev Drug Discov. , vol.3 , pp. 711-715
    • Kola, I.1    Landis, J.2
  • 7
    • 54349090681 scopus 로고    scopus 로고
    • Introduction to Dose Optimization
    • Krishna R, ed. Oxford, UK: Taylor & Francis;
    • Krishna R. Introduction to dose optimization. In: Krishna R, ed. Dose Optimization in Drug Development. Vol. 161. Oxford, UK: Taylor & Francis ; 2006: 1-13.
    • (2006) Dose Optimization in Drug Development , pp. 1-13
    • Krishna, R.1
  • 8
    • 33747084052 scopus 로고    scopus 로고
    • Quantitative clinical pharmacology: Making paradigm shifts a reality
    • Krishna R. Quantitative clinical pharmacology: making paradigm shifts a reality. J Clin Pharmacol. 2006 ; 46: 966-967.
    • (2006) J Clin Pharmacol. , vol.46 , pp. 966-967
    • Krishna, R.1
  • 12
    • 34249045736 scopus 로고    scopus 로고
    • Accessed December 29, 2006.
    • Innovative medicines for Europe, EFPIA, 2004. Available at: http://ec.europa.eu/research/fp6/index_en.cfm?p=1_innomed. Accessed December 29, 2006.
    • (2004) Innovative Medicines for Europe, EFPIA


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.